Evidence map›Paper›PMID 22496569›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids.

Richard C Rogers, Gerlinda E Hermann

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Selective Targeting of TNF Receptors as a Novel Therapeutic Approach.Frontiers in cell and developmental biology · 2020
    Review
  6. Response of catecholaminergic neurons in the mouse hindbrain to glucoprivic stimuli is astrocyte dependent.American journal of physiology. Regulatory, integrative and comparative physiology · 2018
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Richard C RogersLaboratory of Autonomic Neuroscience, Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, USA.
Gerlinda E Hermann
Pennington Biomedical Research Center · US

Funding

TNF, VAGAL TONE AND GASTRIC MOTILITYR01DK052142 · NIDDK · OHIO STATE UNIVERSITY · PI ROGERS, RICHARD C. · 1997 to 2013
$3.1M
Brainstem Esophageal-Gastric ReflexesR01DK056373 · NIDDK · OHIO STATE UNIVERSITY · PI ROGERS, RICHARD C. · 1999 to 2009
$2.1M
Glial-Neural Interactions in Autonomic ControlR01NS060664 · NINDS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI ROGERS, RICHARD C. · 2008 to 2012
$1.6M
NIDDK NIH HHS DK56373NIDDK NIH HHS R01 DK052142NIDDK NIH HHS R01 DK056373NINDS NIH HHS NS52142NINDS NIH HHS NS60664NINDS NIH HHS R01 NS060664
6 · The paper itself

Abstract

The early proinflammatory cytokine tumor necrosis factor (TNF) is released in significant quantities by the activated immune system in response to infection, leukemia, autoimmune disorders, and radiation sickness. Nausea, emesis, and anorexia are common features of these disorders. TNF action on vagal afferent terminals in the brainstem is a likely cause of the malaise associated with these disorders. Our previous work has shown that TNF action to excite vagal afferents occurs as a result of sensitization of ryanodine channels in afferent nerve terminals. For millennia, cannabinoids (CB) have been used to combat the visceral malaise associated with chronic disease, although the mechanism of action has not been clear. Previous work in culture systems suggests that CB1 agonists can suppress neurotransmission by downregulating ryanodine channels through a protein kinase A (PKA)-dependent mechanism. Laser confocal calcium imaging methods were used to directly examine effects of CB1 cannabinoid agonists and TNF on visceral afferent signaling in the rat hindbrain. CB1 agonists blocked the effects of TNF to amplify vagal afferent responsiveness; blockade of PKA with H89 also eliminated the TNF amplification effect. These results help to explain the effectiveness of cannabinoids in blocking the malaise generated by TNF-releasing disease processes by opposing effects on ryanodine channels.

Indexed as

AnimalsBrain StemCalciumCannabinoidsCyclic AMP-Dependent Protein KinasesDiffusion Chambers, CultureElectric StimulationFemaleImage Processing, Computer-AssistedIsoquinolinesMaleMicroscopy, ConfocalNeurons, AfferentPresynaptic TerminalsProtein Kinase InhibitorsRatsCalciumCannabinoidsCyclic AMP-Dependent Protein KinasesIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideProtein Kinase InhibitorsReceptor, Cannabinoid, CB1SulfonamidesTumor Necrosis Factor-alpha

Identifiers

PMID22496569
PMCPMC3342927
OpenAlexW2001247472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.